Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants: A Non-inferiority, Randomized Controlled Trial

NCT03730883 is registered in ClinicalTrials.gov with Princess Anna Mazowiecka Hospital, Warsaw, Poland as lead sponsor.

NCT NCT03730883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03730883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants: A Non-inferiority, Randomized Controlled Trial
Lead sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Phase
Not applicable
Overall status
Unknown status
Start date
January 26, 2019
Completion date
February 1, 2024
Enrollment
214 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

clabsi - central line associated bloodstream infection, growth failure